Chemoinformaics analysis of Delta7-Avenasterol
| Molecular Weight | 412.702 | nRot | 5 |
| Heavy Atom Molecular Weight | 364.318 | nRig | 21 |
| Exact Molecular Weight | 412.371 | nRing | 4 |
| Solubility: LogS | -6.972 | nHRing | 0 |
| Solubility: LogP | 7.236 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 78 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 81.2381 |
| nHD | 1 | BPOL | 48.1539 |
| QED | 0.454 |
| Synth | 4.657 |
| Natural Product Likeliness | 2.944 |
| NR-PPAR-gamma | 0.023 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.111 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.574 |
| MDCK | 0.00000938 |
| BBB | 0.923 |
| PPB | 0.994299 |
| VDSS | 2.001 |
| FU | 0.0143939 |
| CYP1A2-inh | 0.071 |
| CYP1A2-sub | 0.441 |
| CYP2c19-inh | 0.097 |
| CYP2c19-sub | 0.922 |
| CYP2c9-inh | 0.152 |
| CYP2c9-sub | 0.389 |
| CYP2d6-inh | 0.03 |
| CYP2d6-sub | 0.63 |
| CYP3a4-inh | 0.342 |
| CYP3a4-sub | 0.476 |
| CL | 14.256 |
| T12 | 0.01 |
| hERG | 0.004 |
| Ames | 0.012 |
| ROA | 0.027 |
| SkinSen | 0.017 |
| Carcinogencity | 0.046 |
| EI | 0.012 |
| Respiratory | 0.806 |
| NR-Aromatase | 0.01 |
| Antiviral | No |
| Prediction | 0.678113 |